SHARPIN and Its Role in NFκB Activation
Author Information
Author(s): Liang Yanhua
Primary Institution: Yale University School of Medicine
Hypothesis
Does SHARPIN negatively associate with NFκB activation through its interaction with TRAF2?
Conclusion
The study found that SHARPIN negatively associates with NFκB activation, which can be partially compensated by TRAF2 over-expression.
Supporting Evidence
- SHARPIN interacts with TRAF2, which is involved in NFκB activation.
- Loss of SHARPIN function leads to increased NFκB activity in mice.
- Bortezomib, an NFκB inhibitor, alleviates skin problems in SHARPIN-deficient mice.
Takeaway
SHARPIN is a protein that helps control inflammation in the body, and when it's missing, it can cause skin problems in mice.
Methodology
The study used mouse embryonic fibroblasts and various assays including luciferase-based NFκB reporter assays and mass spectrometry to analyze protein interactions.
Limitations
The study primarily used in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website